Inhaled nitric oxide and the longitudinal distribution of PVR in ARDS.

نویسنده

  • A D Farmery
چکیده

Editors,—I read with interest the article by Ruttmann, James and Aronson1 concerning haemodilution with hydroxethyl starch and normal saline. However, I disagree with their conclusion that they have shown that haemodilution per se exerted a procoagulant effect in both groups. Instead, I propose that their conclusion should be that they demonstrated that haemodilution with normal saline resulted in these changes. They did not state that the hydroxyethyl starch was dissolved in 0.9% sodium chloride, although that is the usual formulation. If this were the case, one would expect the changes that were found in the normal saline group to be present also in the hydroxyethyl starch group, just as they described. Normal saline has a pH of 6.1, osmolality of 308 mosmol kg 1, sodium ion concentration of 154 mEq litre 1 and chloride ion concentration of 154 mEq litre 1. As would be expected, post-infusion serum values reflected those of i.v. fluids, especially when the latter were administered rapidly.2 Therefore, after normal saline has been infused, there is an increase in serum sodium, chloride and osmolality, and a decrease in serum pH. Administration of another crystalloid, such as Hartmann’s solution, results in different serum values3 because Hartmann’s solution has a higher pH (6.5), lower osmolality (273 mosmol kg 1 calculated and 254 mosmol kg 1 measured), and different electrolyte concentrations compared with normal saline. The procoagulant changes reported in their article could have been caused by the changes in serum electrolyte concentration, osmolality or pH associated with infusion of normal saline, rather than by haemodilution. It would be interesting to know if the changes in coagulation reported in this article could have been avoided by the use of a different crystalloid such as Hartmann’s solution.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effect of different doses of inhaled nitric oxide on pulmonary capillary pressure and on longitudinal distribution of pulmonary vascular resistance in ARDS.

Inhaled nitric oxide lowers pulmonary capillary pressure (PCP) in animals and in patients with acute respiratory distress syndrome (ARDS). A dose-response relationship in patients with ARDS has not yet been established. Therefore, we studied the effects of four concentrations of nitric oxide (1, 10, 20 and 40 volumes per million (vpm)) in random order, on PCP in 19 patients with ARDS. PCP was e...

متن کامل

Nitration of proteins in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome receiving inhaled nitric oxide.

Inhaled nitric oxide (.NO) is used to improve gas exchange and reduce pulmonary vascular resistance (PVR) in patients with the acute respiratory distress syndrome (ARDS). Although controlled studies have shown no survival benefit, some investigators have suggested that inhaled.NO may have antiinflammatory properties under these circumstances. In contrast, others have speculated that.NO given by...

متن کامل

CARING FOR THE CRITICALLY ILL PATIENT Low-Dose Inhaled Nitric Oxide in Patients With Acute Lung Injury A Randomized Controlled Trial

INHALED NITRIC OXIDE HAS BEEN shown to be a selective pulmonary vasodilator with minimal systemic effects. Nitric oxide has been shown to improve outcome, as measured by the need for extracorporeal membrane oxygenation, in persistent pulmonary hypertension of the newborn. Inhaled nitric oxide has also been shown to improve gas exchange both in animal models of acute respiratory distress syndrom...

متن کامل

Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome

AIM To evaluate the safety and efficacy of inhaled milrinone in acute respiratory distress syndrome (ARDS). METHODS Open-label prospective cross-over pilot study where fifteen adult patients with hypoxemic failure meeting standard ARDS criteria and monitored with a pulmonary artery catheter were recruited in an academic 24-bed medico-surgical intensive care unit. Random sequential administrat...

متن کامل

Inhaled epoprostenol in ARDS.

ARDS presents as a devastating entity characterized by severe hypoxemia, systemic inflammatory response, and high hospital mortality ( 30%).1 Despite years of research, the utilization of mechanical ventilation with low tidal volumes (6 mL/kg of ideal body weight) remains the only therapy that shows reduction in mortality in all severity groups.2 Systemic inflammation with subsequent multiorgan...

متن کامل

Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide.

OBJECTIVE To determine the costs and long-term outcomes of acute respiratory distress syndrome (ARDS) in previously healthy adults. To determine whether treatment with inhaled nitric oxide affects these costs and outcomes. DESIGN One-year follow-up of a randomized trial of inhaled nitric oxide. Hospital bills were collected, and follow-up was performed at hospital discharge, 6 months, and 1 y...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • British journal of anaesthesia

دوره 81 6  شماره 

صفحات  -

تاریخ انتشار 1998